Literature DB >> 29988304

Stereotactic radiosurgery for resected brain metastasis: Cavity dynamics and factors affecting its evolution.

Majed Alghamdi1,2, Yaser Hasan1, Mark Ruschin1, Eshetu G Atenafu3, Sten Myrehaug1, Chia-Lin Tseng1, Julian Spears4, Todd Mainprize4, Arjun Sahgal1, Hany Soliman1.   

Abstract

OBJECTIVE: To determine changes in post-surgical cavity volume for metastases based on time from surgery, pre-operative tumor dimensions and other predictors, in patients planned for post-operative stereotactic radiosurgery (SRS).
METHODS: Patients with resected brain metastases from a primary solid tumor, treated with post-operative surgical cavity SRS from 2008 to 2014 were identified from an institutional prospective database. The segmented three-dimensional (3D) volume of the pre-operative tumor and post-operative surgical cavity were determined based on MRI and percent volume change was calculated. Patients were grouped according to early (<21 days), intermediate (22-42 days), and late (>42 days) intervals based on the number of days between the date of surgery and the treatment planning MRI. Potential predictive factors including tumor size, location, age, dural involvement, and degree of surgical resection were also analyzed.
RESULTS: Sixty-one cavities in 59 patients were evaluated. Overall, a significant volume reduction (4cm3, p=0.03) was observed comparing tumor and cavity volumes. For larger tumors, an average volume reduction of 11.6% (p=0.01) was observed compared to an increase of 34.4% in smaller tumors (p=0.69). For both large and small tumors, cavities were larger in the early interval especially for smaller tumors. During the intermediate interval, a significant volume reduction was observed for larger tumors (28%, p=0.0007). Tumor size, dural involvement, age and time from surgery were significant predictors for volume change on univariate analysis. On multivariate analysis, tumor size, dural involvement and time from surgery were significant.
CONCLUSION: Tumor size (>3cm), dural involvement and longer time from surgery were significant predictors of cavity volume reduction. Caution must be taken when treating cavities in the early (<21 days) interval after surgery as it may lead to irradiating more normal tissue especially in small tumors.

Entities:  

Keywords:  brain metastasis; cavity dynamics; fractionated stereotactic radiosurgery; stereotactic radiosurgery

Year:  2018        PMID: 29988304      PMCID: PMC6018046     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  7 in total

1.  Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery.

Authors:  Banu Atalar; Clara Y H Choi; Griffith R Harsh; Steven D Chang; Iris C Gibbs; John R Adler; Scott G Soltys
Journal:  Neurosurgery       Date:  2013-02       Impact factor: 4.654

2.  Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery.

Authors:  Lesley A Jarvis; Nathan E Simmons; Marc Bellerive; Kadir Erkmen; Clifford J Eskey; David J Gladstone; Eugen B Hug; David W Roberts; Alan C Hartford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-09       Impact factor: 7.038

3.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Authors:  Paul D Brown; Kurt Jaeckle; Karla V Ballman; Elana Farace; Jane H Cerhan; S Keith Anderson; Xiomara W Carrero; Fred G Barker; Richard Deming; Stuart H Burri; Cynthia Ménard; Caroline Chung; Volker W Stieber; Bruce E Pollock; Evanthia Galanis; Jan C Buckner; Anthony L Asher
Journal:  JAMA       Date:  2016-07-26       Impact factor: 56.272

4.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

5.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

6.  Surgical Cavity Constriction and Local Progression Between Resection and Adjuvant Radiosurgery for Brain Metastases.

Authors:  Jugal K Shah; Matthew B Potts; Penny K Sneed; Manish K Aghi; Michael W McDermott
Journal:  Cureus       Date:  2016-04-19

Review 7.  Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases.

Authors:  Hany Soliman; Sunit Das; David A Larson; Arjun Sahgal
Journal:  Oncotarget       Date:  2016-03-15
  7 in total
  8 in total

1.  Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases.

Authors:  Timothy K Nguyen; Arjun Sahgal; Jay Detsky; Eshetu G Atenafu; Sten Myrehaug; Chia-Lin Tseng; Zain Husain; Chris Heyn; Pejman Maralani; Mark Ruschin; James Perry; Hany Soliman
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

Review 2.  Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases.

Authors:  Cristian Udovicich; Claire Phillips; David L Kok; Damien Tange; Nikki M Plumridge; Roshan S Prabhu; Neda Haghighi
Journal:  Curr Oncol Rep       Date:  2019-07-04       Impact factor: 5.075

3.  Inter-fraction dynamics during post-operative 5 fraction cavity hypofractionated stereotactic radiotherapy with a MR LINAC: a prospective serial imaging study.

Authors:  Hendrick Tan; James Stewart; Mark Ruschin; Michael H Wang; Sten Myrehaug; Chia-Lin Tseng; Jay Detsky; Zain Husain; Hanbo Chen; Arjun Sahgal; Hany Soliman
Journal:  J Neurooncol       Date:  2022-01-03       Impact factor: 4.130

4.  Optimal timing of radiotherapy following brain metastases surgery.

Authors:  Nasser K Yaghi; Stephanie Radu; Joseph G Nugent; David J Mazur-Hart; Brandi W Pang; Stephen G Bowden; Blair Murphy; Seunggu J Han
Journal:  Neurooncol Pract       Date:  2022-02-02

Review 5.  The Relationship Between Tumor Volume and Timing of Post-resection Stereotactic Radiosurgery to Maximize Local Control: A Critical Review.

Authors:  Melissa Yuan; Eltion Behrami; Susan Pannullo; Theodore H Schwartz; A Gabriella Wernicke
Journal:  Cureus       Date:  2019-09-25

Review 6.  Current status and recent advances in resection cavity irradiation of brain metastases.

Authors:  Giuseppe Minniti; Maximilian Niyazi; Nicolaus Andratschke; Matthias Guckenberger; Joshua D Palmer; Helen A Shih; Simon S Lo; Scott Soltys; Ivana Russo; Paul D Brown; Claus Belka
Journal:  Radiat Oncol       Date:  2021-04-15       Impact factor: 3.481

7.  On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data.

Authors:  Barbara Witulla; Nicole Goerig; Florian Putz; Benjamin Frey; Tobias Engelhorn; Arnd Dörfler; Michael Uder; Rainer Fietkau; Christoph Bert; Frederik Bernd Laun
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240

8.  Improved dosimetric accuracy with semi-automatic contour propagation of organs-at-risk in glioblastoma patients undergoing chemoradiation.

Authors:  Sangjune Lee; James Stewart; Young Lee; Sten Myrehaug; Arjun Sahgal; Mark Ruschin; Chia-Lin Tseng
Journal:  J Appl Clin Med Phys       Date:  2019-10-31       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.